NOTICE: Due to a lapse in annual appropriations, most of this website is not being updated. Learn more.

Form submissions will still be accepted but will not receive responses at this time. Sections of this site for programs using non-appropriated funds (such as NVLAP) or those that are excepted from the shutdown (such as CHIPS and NVD) will continue to be updated.

U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

PUBLICATIONS

Assessment of the Higher Order Structure of Formulated Monoclonal Antibody Therapeutics by 2D Methyl Correlated NMR and Principal Component Analysis.

Published

Author(s)

Luke Arbogast, Frank Delaglio, Robert G. Brinson, John Marino

Abstract

Characterization of the higher order structure (HOS) of protein therapeutics and in particular, monoclonal antibodies, by 2D 1H-13C methyl correlated NMR has been demonstrated as precise and robust. Such characterization can be greatly enhanced when collections of spectra are analyzed using multivariate approaches such as principal component analysis (PCA), allowing for the detection and identification of small structural differences in analytes that may otherwise fall below the limit of detection of conventional spectral analysis. A major limitation to this approach is the presence of aliphatic signals from formulation or excipient components which result in spectral interference with the protein signal of interest; however, the recently described Selective Excipient Reduction and Removal (SIERRA) filter greatly reduces this issue. Here we will outline how basic 2D 1H-13C methyl correlated NMR may be combined with the SIERRA approach to collect 'clean' NMR spectra of formulated monoclonal antibody therapeutics (i.e., protein spectra free of interfering component signals) and how series of such spectra may be used for HOS characterization by direct PCA of the series spectral matrix.
Citation
Current Protocols in Protein Science
Pub Type
Journals

Download Paper

https://dx.doi.org/10.1002/cpps.105
Local Download

Keywords

Monoclonal antibodies, biotherapeutics, nuclear magnetic resonance, SIERRA, principal component analysis
Biomanufacturing

Citation

Arbogast, L. , Delaglio, F. , Brinson, R. and Marino, J. (2020), Assessment of the Higher Order Structure of Formulated Monoclonal Antibody Therapeutics by 2D Methyl Correlated NMR and Principal Component Analysis., Current Protocols in Protein Science, [online], https://dx.doi.org/10.1002/cpps.105 (Accessed October 12, 2025)

Issues

If you have any questions about this publication or are having problems accessing it, please contact [email protected].

Created May 13, 2020, Updated March 1, 2021
Was this page helpful?